MABVAX THERAPEUTICS INC
SAN DIEGO, CA · Founded 2006 · CIK 0001429968 · Biotech · Acquired
Fully human antibody discovery platform for cancer therapeutics
mabvax.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $16M
- 3 Form D · Jul 2014
- 147 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 4
- 2 granted · 2 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓200920102011201220132014
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $500,010 | |
| Private capital raised | Form D · SEC | $12,050,998 | |
| Private capital raised | Form D · SEC | $3,040,635 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2475 | Aulos Bioscience, Inc. | — | $20M |
| 2476 | Surf Bio, Inc. | — | $16M |
| 2477 | ImmunGene | — | — |
| 2478 | MABVAX THERAPEUTICS INC | — | $16M |
| 2479 | INGENUITY SYSTEMS INC | — | $15M |
| 2480 | MANHATTAN PHARMACEUTICALS INC | — | $14M |
| 2481 | CORNERSTONE PHARMACEUTICALS INC | — | $13M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- James AntonopoulosDirector
- JIM ANTONOPOULOSDirector
- KENNETH COHENDirector
- J. HansenDirector · Executive Officer
- J. HANSENDirector · Executive Officer
- GREGORY HANSONExecutive Officer
- Douglas LindDirector
- Philip LivingstonDirector
- PHILIP LIVINGSTONDirector · Executive Officer
- PAUL MAIERDirector
- JEFFREY RAVETCHDirector
- Nick StephensDirector
Patents
- Human Monoclonal Antibodies To Ganglioside GD2granted
- Nucleic Acids Encoding Human Antibodies To Sialyl-Lewis Agranted
- Human Monoclonal Antibodies To Ganglioside GD2application
- Nucleic Acids Encoding Human Antibodies To Sialyl-lewis Aapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.